Adalvo Ltd. Pharmadox Healthcare Ltd. STADA Arzneimittel AG
PolandAll drugs from this manufacturer
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 5 mg ATC: L04AX04
-
The medicinal product is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 10 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 15 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma, and follicular lymphoma.
Dosage form: capsules, hard
Active substance Dosage lenalidomide 20 mg ATC: L04AX04
-
The medicine is used in adults for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
Dosage form: capsules, hard
Active substance Dosage lenalidomide 25 mg ATC: L04AX04